Want to join the conversation?
$CAG ended 4Q16 with $835MM of cash on hand and no outstanding commercial paper borrowings. Capex in 4Q16 was $150MM. Dividends were $109MM. For the year, $CAG repaid approx. $2.5Bil of debt mainly from the proceeds from the sale of the private label operations.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)